Three-year visual outcomes after brolucizumab in patients with neovascular age-related macular degeneration
The purpose of this study is to investigate the 3-year outcomes of intravitreal brolucizumab and determine the factors that affect the visual acuity (VA) in patients with neovascular age-related macular degene...
https://bmcophthalmol.biomedce....ntral.com/articles/1
Discover the world at Altruu, The Discovery Engine